Early plus delayed hirudin reduces restenosis in the atherosclerotic rabbit more than early administration alone: potential implications for dosing of antithrombin agents.

BACKGROUND A 2-hour infusion of r-hirudin at the time of balloon angioplasty limits restenosis in atherosclerotic rabbits. Because thrombin activity in the vessel wall after angioplasty remains high for 48 to 72 hours, we hypothesized that a second infusion of hirudin at 24 hours would reduce restenosis more than early treatment alone. METHODS AND RESULTS Femoral atherosclerosis was induced in 35 rabbits by air desiccation injury and a high-cholesterol diet. At the time of angioplasty, rabbits were randomly assigned to 1 of 4 groups: controls: heparin bolus, saline infusion at 24 hours; early hirudin: hirudin bolus+2 hours' infusion, saline infusion at 24 hours; delayed hirudin: heparin bolus, hirudin infusion+/-bolus at 24 hours; and early+delayed hirudin: hirudin bolus+2 hours' infusion, hirudin infusion+/-bolus at 24 hours. Rabbits were euthanized after 28 days. The early+delayed hirudin treatment group had less loss of minimal lumen diameter by angiography at 28 days. By histomorphometry, cross-sectional area narrowing by plaque was least in the early+delayed treatment group compared with controls (P=0.0001), early hirudin (P=0.01), or delayed hirudin (P=0.001). The early+delayed hirudin group also had a significant reduction in absolute plaque area and an improvement in lumen area compared with the other groups. No differences were observed between treatment groups with respect to the cross-sectional area encompassed by the internal or external elastic laminae. CONCLUSIONS Combined early+delayed administration of hirudin significantly reduces angiographic restenosis and cross-sectional area narrowing by plaque compared with early or late treatment alone. These results suggest that restenosis after balloon angioplasty is markedly influenced by thrombin-mediated events not only occurring early but also extending beyond the first 24 hours in this model.

[1]  W. Roberts,et al.  Predictors of luminal narrowing by neointima after angioplasty in atherosclerotic rabbits. , 1997, Cardiovascular research.

[2]  M. Leon,et al.  Remodeling of human coronary arteries undergoing coronary angioplasty or atherectomy. , 1997, Circulation.

[3]  M. Leon,et al.  Contribution of inadequate arterial remodeling to the development of focal coronary artery stenoses. An intravascular ultrasound study. , 1997, Circulation.

[4]  B. Hillen,et al.  Impact of local atherosclerotic remodeling on the calculation of percent luminal narrowing. , 1997, The American journal of cardiology.

[5]  G. Owens,et al.  Arterial thrombin activity after angioplasty in an atherosclerotic rabbit model: time course and effect of hirudin. , 1996, Circulation.

[6]  G. Stouffer,et al.  Effect of thrombin inhibition with desulfatohirudin on early kinetics of cellular proliferation after balloon angioplasty in atherosclerotic rabbits. , 1996, Circulation.

[7]  P. Serruys,et al.  A comparison of hirudin with heparin in the prevention of restenosis after coronary angioplasty. Helvetica Investigators. , 1995, The New England journal of medicine.

[8]  B. Chaitman,et al.  Treatment with bivalirudin (Hirulog) as compared with heparin during coronary angioplasty for unstable or postinfarction angina. Hirulog Angioplasty Study Investigators. , 1995, The New England journal of medicine.

[9]  G. Owens,et al.  Thrombin-induced mitogenesis in cultured aortic smooth muscle cells requires prolonged thrombin exposure. , 1995, The American journal of physiology.

[10]  B Hillen,et al.  Paradoxical arterial wall shrinkage may contribute to luminal narrowing of human atherosclerotic femoral arteries. , 1995, Circulation.

[11]  W. Roberts,et al.  Geometric Remodeling Is Not the Principal Pathogenetic Process in Restenosis After Balloon Angioplasty: Evidence From Correlative Angiographic‐Histomorphometric Studies of Atherosclerotic Arteries in Rabbits , 1994, Circulation.

[12]  T. Ryan,et al.  Differences in compensatory vessel enlargement, not intimal formation, account for restenosis after angioplasty in the hypercholesterolemic rabbit model. , 1994, Circulation.

[13]  C. Dunwiddie,et al.  Specific factor Xa inhibition reduces restenosis after balloon angioplasty of atherosclerotic femoral arteries in rabbits. , 1994, Circulation.

[14]  W. Roberts,et al.  Effectiveness of Recombinant Desulphatohirudin in Reducing Restenosis After Balloon Angioplasty of Atherosclerotic Femoral Arteries in Rabbits , 1991, Circulation.

[15]  W J Penny,et al.  Hirudin, heparin, and placebo during deep arterial injury in the pig. The in vivo role of thrombin in platelet-mediated thrombosis. , 1990, Circulation.

[16]  C. Haudenschild,et al.  Influence of inflation pressure and balloon size on the development of intimal hyperplasia after balloon angioplasty. A study in the atherosclerotic rabbit. , 1989, Circulation.

[17]  Janice,et al.  Thrombin is an important mediator of platelet aggregation in stenosed canine coronary arteries with endothelial injury. , 1989, The Journal of clinical investigation.

[18]  C. Zarins,et al.  Compensatory enlargement of human atherosclerotic coronary arteries. , 1987, The New England journal of medicine.

[19]  G. Wolf,et al.  New rabbit atherosclerosis model for the investigation of transluminal angioplasty. , 1981, Investigative radiology.

[20]  D. Kritchevsky,et al.  Experimental atherosclerosis in rabbits fed cholesterol-free diets. , 1964, Atherosclerosis.

[21]  S. Coughlin,et al.  Thrombin stimulates proliferation of cultured rat aortic smooth muscle cells by a proteolytically activated receptor. , 1993, The Journal of clinical investigation.